ACP Diabetes Monthly
Welcome to this month's issue of ACP Diabetes Monthly, an update for internists published by the American College of Physicians.
In the News for the month of November 2014
Urine, blood glucose self-monitoring equally effective for new type 2 patients
Patients with newly diagnosed type 2 diabetes had equal improvement in HbA1c whether they self-monitored by testing their blood or urine glucose, a study found. More...
Mortality rates may differ among sulfonylureas, meta-analysis finds
Among sulfonylureas, gliclazide and glimepiride were associated with a lower risk of all-cause and cardiovascular-related mortality than glyburide, a meta-analysis found. More...
EMRs could be used to help improve diabetes diagnosis, quality of care
Through accurate coding, electronic medical records (EMRs) may help improve diagnosis of diabetes and quality of care, according to a recent study. More...
MKSAP Quiz: Kidney testing in a type 2 diabetic
This month's quiz asks readers to evaluate a 67-year-old man following a recent diagnosis of type 2 diabetes mellitus. More...
From ACP Internist Weekly
Analysis finds several treatments for painful diabetic neuropathy more effective than placebo
A large meta-analysis recently compared the effectiveness of pharmacological treatments for painful diabetic neuropathy. More...
From ACP Hospitalist Weekly
Random or fasting glucose tests can target diabetes screening after MI
Random or fasting glucose measurements can be used to screen for diabetes in patients admitted for acute myocardial infarction, a study found. More...
Glucose monitoring system approved specifically for critical care units
The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized. More...
Combo of metformin and dapagliflozin approved
A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA. More...
Spotlight on metformin
Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month. More...
Physician editor: David V. O'Dell, MD, FACP
Has Your Contact Information Changed?
To change your e-mail address or other contact information in our records, go here or call 800-523-1546, ext. 2600 (M-F, 9 a.m. - 5 p.m. ET).
About Your Subscription
You are receiving this newsletter as a benefit of your ACP membership. To unsubscribe, simply send a blank e-mail to leave-105814-17003158N@acpnews.org.
ACP Diabetes Monthly is a monthly newsletter produced by the staff of ACP Internist. Please forward any comments or suggestions to firstname.lastname@example.org.
ACP respects your privacy and will not sell, lease or share your e-mail address with any other organization. The College will only use e-mail for the purpose of conducting College business and for communicating with College members.
Copyright © by American College of Physicians.
A 50-year-old man is evaluated in follow-up for a recent diagnosis of cirrhosis secondary to nonalcoholic steatohepatitis. He has a history of asthma, type 2 diabetes mellitus, hyperlipidemia, and obesity. His current medications are inhaled fluticasone, montelukast, insulin glargine, insulin lispro, simvastatin, and lisinopril. Following a physical exam, lab studies, and upper endoscopy, what is the most appropriate treatment?
MKSAP 16® Holiday Special: Save 10%
Use MKSAP 16 to earn MOC points, prepare for ABIM exams and assess your clinical knowledge. For a limited time save 10% when you use priority code MKPROMO! Order now.
Maintenance of Certification:
What if I Still Don't Know Where to Start?
Because the rules are complex and may apply differently depending on when you last certified, ACP has developed a MOC Navigator. This FREE tool can help you understand the impact of MOC, review requirements, guide you in selecting ways to meet the requirements, show you how to enroll, and more. Start navigating now.